YTD, Sensex and Nifty have gained by 6-7% and are trading above pivotal levels of 83,400 and 25,460. The outlook for 2025 and ...

Of the 33 analysts that have coverage on the stock, 17 have a "buy" rating, while eight each have "hold" and "sell" ratings.

Heart disease remains one of the leading causes of death in the country, accounting for nearly 7.8% of total mortalities ...